Guang-Yu L.,First Affiliated Hospital Of Guangxi Medical Universityguangxip ina |
Hai-Yan L.,Oncological Internal MedicinePeoples Hospital of Guangxi Zhuang Automous RegionGuangxiP. R. China |
Ji-Hong L.,First Affiliated Hospital Of Guangxi Medical Universityguangxip ina |
Yun-Cong M.,First Affiliated Hospital Of Guangxi Medical Universityguangxip ina |
And 3 more authors.
Molecular Reproduction and Development | Year: 2016
SUMMARY: Myeloid cell leukemia-1 (MCL1), an anti-apoptotic member of the BCL2 family, is expressed abundantly in the testis. Previous characterization revealed that MCL1 is expressed exclusively in the Leydig cells in the mouse testis, yet what it does in these cells remains unknown. We therefore analyzed testosterone biosynthesis in isolated primary Leydig cells and the MA-10 cell line, in which MCL1 was knocked down using an siRNA strategy. The mRNA abundance of the steroidogenic genes Star, Cyp11a1, Cyp17a1, Hsd3b1, Srd5a, and the luteinizing hormone/choriogonadotropin receptor Lhcgr were significantly reduced following MCL1 knockdown. Of the two enzymes required for testosterone biosynthesis, STAR and P450 SCC (encoded by Cyp11a1) enzyme abundance was also reduced following Mcl1 siRNA treatment, possibly leading to the reduced production of sex steroid precursors, and testosterone in these knockdown cells. Despite its classification as an anti-apoptosis protein, Mcl1 siRNA treatment did not affect cell survival. Collectively, our findings indicate that MCL1 plays a pivotal role in Leydig-cell steroidogenesis, and might provide novel insights into metabolic regulation in this cell. Mol. Reprod. Dev. 2016. © 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc. January 2016 10.1002/mrd.22614 Research Article Research Articles © 2016 Wiley Periodicals, Inc.. Source